Your email has been successfully added to our mailing list.

×
0.00725952813067135 0.00725952813067135 0.00362976406533568 -0.001814882032668 0.0145190562613429 0.0344827586206896 0.0889292196007258 0.0580762250453719
Stock impact report

GenMark Q1 revenue up big on COVID-19 boost; shares up 29% after hours [Seeking Alpha]

GENMARK DIAGNOSTICS (GNMK) 
Last genmark diagnostics earnings: 3/2 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.genmarkdx.com/investor-relations
Company Research Source: Seeking Alpha
Citing a (most likely rare) positive impact from COVID-19, GenMark Diagnostics (NASDAQ:GNMKQ1 revenueAbout 80% of gross ePlex placements (net of 54 in the quarter) were from customers interested in COVID-19 testing. SARS-CoV-2 consumables accounted for ~2% of total ePlex revenue.2020 revenue guidance increased to $112M - 122M from $100M - 110M.Management will provide another update during its earnings call next month.Shares up29% Show less Read more
Impact Snapshot
Event Time:
GNMK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for GNMK alerts
Opt-in for
GNMK alerts

from News Quantified
Opt-in for
GNMK alerts

from News Quantified